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Abstract
Inotilone was isolated from Phellinus linteus. The anti-inflammatory effects of inotilone were studied by using
lipopolysaccharide (LPS)-stimulated mouse macrophage RAW264.7 cells and l-carrageenan (Carr)-induced hind mouse
paw edema model. Inotilone was tested for its ability to reduce nitric oxide (NO) production, and the inducible nitric oxide
synthase (iNOS) expression. Inotilone was tested in the inhibitor of mitogen-activated protein kinase (MAPK) [extracellular
signal-regulated protein kinase (ERK), c-Jun NH2-terminal kinase (JNK), p38], and nuclear factor-kB (NF-kB), matrix-
metalloproteinase (MMP)-9 protein expressions in LPS-stimulated RAW264.7 cells. When RAW264.7 macrophages were
treated with inotilone together with LPS, a significant concentration-dependent inhibition of NO production was detected.
Western blotting revealed that inotilone blocked the protein expression of iNOS, NF-kB, and MMP-9 in LPS-stimulated
RAW264.7 macrophages, significantly. Inotilone also inhibited LPS-induced ERK, JNK, and p38 phosphorylation. In in vivo
tests, inotilone decreased the paw edema at the 4
th and the 5
th h after Carr administration, and it increased the activities of
catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GPx). We also demonstrated that inotilone
significantly attenuated the malondialdehyde (MDA) level in the edema paw at the 5
th h after Carr injection. Inotilone
decreased the NO and tumor necrosis factor (TNF-a) levels on serum at the 5
th h after Carr injection. Western blotting
revealed that inotilone decreased Carr-induced iNOS, cyclooxygenase-2 (COX-2), NF-kB, and MMP-9 expressions at the 5
th h
in the edema paw. An intraperitoneal (i.p.) injection treatment with inotilone diminished neutrophil infiltration into sites of
inflammation, as did indomethacin (Indo). The anti-inflammatory activities of inotilone might be related to decrease the
levels of MDA, iNOS, COX-2, NF-kB, and MMP-9 and increase the activities of CAT, SOD, and GPx in the paw edema through
the suppression of TNF-a and NO. This study presents the potential utilization of inotilone, as a lead for the development of
anti-inflammatory drugs.
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Introduction
Inflammation, a physiological response to infection or injury,
plays a critical role in chronic diseases, including asthma,
rheumatoid arthritis, atherosclerosis, and Alzheimer’s disease,
and it plays a role in various human cancers [1]. Among its
mediators, inducible nitric oxide synthase (iNOS) and cyclooxy-
genase-2 (COX-2) are important enzymes that regulate inflam-
matory processes [2]. In addition, one of the major factors
involved in the inflammation response is induced by lipopolysac-
charide (LPS) and various inflammatory mediator cytokines such
as interferon, interleukins, and tumor necrosis factor (TNF)-a [3].
Many researchers reported that inflammatory effect induced by l-
carrageenan (Carr) could be associated with free radical formation.
Free radical, prostaglandin and NO will be released when
administrating with Carr for 1–5 h. The edema effect was raised
to maximum at the 3
th h and its malondialdehyde (MDA)
production was due to free radical attack plasma membrane [4].
Therefore, in this paper, we examined the anti-inflammatory
effects of inotilone on LPS-induced RAW264.7 cells and Carr-
induced paw edema in mice.
The generation of reactive oxygen species (ROS) has been
shown to modulate both the expression and activity of MMPs [5].
ROS also increases the expression of MMPs via cell signaling
pathways, such as the mitogen activated protein kinase (MAPK)
pathways that are regulated by redox-sensitive phosphatases [6].
MAPK pathways are the evolutionarily conserved kinase module
that links extracellular signals to the machinery controlling
fundamental cellular processes such as growth, proliferation,
differentiation, and cell death [7]. An important amount of
evidence has indicated that macrophages under certain stimuli
induce matrix metalloproteinase 9 (MMP-9) expression and
protein secretion through the activation of extracellular signal-
regulated protein kinase (ERK) and nuclear factor-kB (NF-kB)
signaling pathways [5]. MMP-9 expression in macrophages,
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lular matrix remodeling [8].
Phellinus linteus (Berk. & M.A. Curt.) (PL) is a mushroom that
belongs to the genus Phellinus and it is commonly called
‘‘Sangwhang’’ in Taiwan. It is popular in oriental countries and
has been traditionally used as food and medicine. PL contains
many bioactive compounds, and it is known to prevent various
diseases, such as cancer, ulcer, bacterial and viral infections and
diabetes [9]. Recently, PL has been exhibited various biological
activities, including anti-oxidative, anti-inammatory, cytotoxic,
anti-platelet aggregation, anti-diabetic, anti-dementia, and anti-
viral effects [10]. PL has been isolated several aromatic
compounds from the cultured mycelia such as hydroxybenzalde-
hyde, caffeic acid, hispolon, hispidin, and inotilone [11]. We
recently reported that inotilone had previously been shown to
possess anti-inflammatory [12], and a-glucosidase and aldose
reductase inhibitory activities [9]. This study examined the anti-
inflammatory effects of inotilone by using LPS-stimulated
RAW264.7 cell in vitro and Carr-induced mouse paw edema
model in vivo. The study also evaluated the effect of inotilone on
MMP-9 expression associated NF-kB and MAPK signaling
pathways to reveal molecular mechanism.
Methods
Chemicals
LPS (endotoxin from Escherichia coli, serotype 0127:B8), Carr
(Type IV), Indo, MTT (3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphe-
nyltetrazolium bromide) and other chemicals were purchased from
Sigma Chemical Co. (St. Louis, USA). TNF-a was purchased from
Biosource International Inc. (Camarillo, CA, USA). Anti-iNOS,
anti-COX-2, anti-b-actin antibody (Santa Cruz, USA) and a
protein assay kit (Bio-Rad Laboratories Ltd., Watford, Herts,
U.K.) were obtained as indicated. Poly-(vinylidene fluoride)
membrane (Immobilon-P) was obtained from Millipore Corp.
(Bedford, MA, USA). The antibody against MMP-9, NF-kB,
ERK, JNK, and p38 proteins and phosphorylated proteins were
purchased from Cell Signaling Technology (Beverly, MA).
Isolation and Characterization of Inotilone from Fruiting
Body of PL
The fruiting body of PL (about 1.0 kg, air dry weight) was
powdered, and extracted with 6 L 95% EtOH at room
temperature (3 times, 72 h each). Extracts were filtered and
combined together, and then evaporated at 40uC (N-11, Eyela,
Japan) to dryness under reduced pressure to give a dark brown
residue (40 g). The yield obtained for PL is about 4%. The crude
extract was suspended in H2O (1 L), and then partitioned with 1 L
n-hexane (62), 1 L EtOAc (62) and 1 L n-butanol (62),
successively.
Inotilone was purified from the EtOAc soluble portion (8 g) by a
bioassay-guid separation. A portion of the active EtOAc fraction
was subjected to silica gel chromatography using stepwise CHCl3-
MeOH (9:1, 8:2, 1:1 v/v) as eluent. Final purification was achieved
by preparative HPLC (Spherisorb ODS-2 RP18, 5 mm (Promo-
chem), 250625 mm, acetonitrie-H2O (83:17 v/v), at a flow rate of
10 mL/min and UV detection at 375 nm). The identification of
inotilone was performed by comparing their physical spectral data
with literature values [9].
Inotilone.
1H NMR (400 MHz, DMSO) d 2.55 (s, 3 H,
CH3), 5.80 (s, 1 H, CH), 6.49 (s, 1 H, CH), 6.80 (d, 1 H,
J=8.4 Hz, ArH), 7.16 (dd, 1 H, J=8.4, 2.0 Hz, ArH), 7.34 (d,
1H ,J=2.0 Hz, ArH);
13C NMR (100 MHz, DMSO) d 15.9,
105.7, 112.3, 116.2, 118.2, 123.1, 125.0, 144.6, 145.7, 148.4,
180.9, 187.0.
Animals
Imprinting control region (ICR; 6–8 weeks male) mice were
obtained from the BioLASCO Taiwan Co., Ltd. The animals
were kept in plexiglass cages at a constant temperature of 2261uC,
and relative humidity of 5565% with 12 h dark-light cycle for at
least 2 weeks before the experiment. They were given food and
water ad libitum. This animal study was approved by the
Institutional Animal Care and Use Committee (IACUC) of the
China Medical University, Taiwan, and all animal procedures
were performed according to the IACUC policy. And the
recommendations of the Committee for Research and Ethical
Issues of the International Association for the Study of Pain (IASP)
Ethical Guidelines (Committee for Research and Ethical Issues of
the IASP, 1983) were adhered in these studies [13]. In particular,
the duration of the experiments was as short as possible and the
number of animals was kept to a minimum.
After a 2-week adaptation period, male ICR mice (18–25 g)
were randomly assigned to four groups (n=6) of the animals in the
study. The control group received normal saline (intraperitoneal;
i.p.). The other three groups included a Carr-treated, a positive
control (Carr + Indo) and inotilone administered groups (Carr +
inotilone).
Cell Culture
A murine macrophage cell line RAW264.7 (BCRC No. 60001)
was purchased from the Bioresources Collection and Research
Center (BCRC) of the Food Industry Research and Development
Institute (Hsinchu, Taiwan). Cells were cultured in plastic dishes
containing Dulbecco’s Modified Eagle Medium (DMEM, Sigma,
St. Louis, MO, USA) supplemented with 10% fetal bovine serum
(FBS, Sigma, USA) in a CO2 incubator (5% CO2 in air) at 37uC
and subcultured every 3 days at a dilution of 1:5 using 0.05%
trypsin–0.02% EDTA in Ca
2+-, Mg
2+- free phosphate-buffered
saline (DPBS).
Cell Viability
Cells (2610
5) were cultured in 96-well plate containing DMEM
supplemented with 10% FBS for 1 day to become nearly
confluent. Then cells were cultured with inotilone in the presence
of 100 ng/mL LPS for 24 h or 1 h. After that, the cells were
washed twice with DPBS and incubated with 100 mL of 0.5 mg/
mL MTT for 2 h at 37uC testing for cell viability. The medium
was then discarded and 100 mL dimethyl sulfoxide (DMSO) was
added. After 30-min incubation, absorbance at 570 nm was read
by using a microplate reader (Molecular Devices, Orleans Drive,
Sunnyvale, CA).
Measurement of Nitric Oxide/Nitrite
NO production was indirectly assessed by measuring the
nitrite levels in the cultured media and serum determined by a
colorimetric method based on the Griess reaction [14]. The cells
were incubated with inotilone (0, 1.56, 3.12, 6.25, 12.5, and
25 mM) in the presence of LPS (100 ng/mL) at 37uC for 24 h.
Then, cells were dispensed into 96-well plates, and 100 mLo f
each supernatant was mixed with the same volume of Griess
reagent (1% sulfanilamide, 0.1% naphthyl ethylenediamine
dihydrochloride and 5% phosphoric acid) and incubated at
room temperature for 10 min, the absorbance was measured at
540 nm with a Micro-Reader (Molecular Devices, Orleans Drive,
Sunnyvale, CA). Serum samples were diluted four times with
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sulfate (300 g/L) to a final concentration of 15 g/L. After
centrifugation at 10,0006g for 5 min at room temperature,
100 mL supernatant was applied to a microtiter plate well,
followed by 100 mL of Griess reagent. After 10 min of color
development at room temperature, the absorbance was measured
at 540 nm with a Micro-Reader. By using sodium nitrite to
generate a standard curve, the concentration of nitrite was
measured form absorbance at 540 nm.
Determination of MMP-9 by Zymography
MMP in the medium released from RAW264.7 cells was
assayed using gelatin zymography (7.5% zymogram gelatin gels)
according to the methods reported by Liao et al. (2006) [15]
with some modification. Briefly, the culture medium was
electrophoresed (120 V for 90 min) in a 10% SDS-PAGE gel
containing 0.1% gelatin. The gel was then washed at room
temperature in a solution containing 2.5% (v/v) Triton X-100
with two changes and subsequently transferred to a reaction
buffer for enzymatic reaction containing 1% NaN3,1 0 m M
CaCl2 and 40 mM Tris–HCl, pH 8.0, at 37uC with shaking
overnight (for 12–15 h). Finally, the MMP gel was stained for
30 min with 0.25% (w/v) Coomassie blue in 10% acetic acid (v/
v) and 20% methanol (v/v) and destained in 10% acetic acid (v/
v) and 20% methanol (v/v).
Carr-induced Edema
The Carr-induced hind paw edema model was used for
determination of anti-inflammatory activity [16]. Animals were
i.p. treated with inotilone (1.25, 2.50, and 5 mg/kg), Indo (10 mg/
kg) or normal saline, 30 min prior to injection of 1% Carr (50 mL)
in the plantar side of right hind paws of the mice. The paw volume
was measured immediately after Carr injection and at 1, 2, 3, 4,
and 5 h intervals after the administration of the edematogenic
agent using a plethysmometer (model 7159, Ugo Basile, Varese,
Italy). The degree of swelling induced was evaluated by the ratio
a/b, where was the volume of the right hind paw after Carr
treatment, and b was the volume of the right hind paw before Carr
treatment. Indo was used as a positive control. After 5 hrs, the
animals were sacrificed and the Carr-induced edema feet were
dissected and stored at 280uC. Also, blood were withdrawn and
kept at 280uC.
In the secondary experiment, the right hind paw tissue and paw
edema tissue took at the 5
th h. The right hind paw tissue was rinsed
in ice-cold normal saline, and immediately placed in cold normal
saline four times their volume and homogenized at 4uC. Then the
homogenate was centrifuged at 12,0006g for 5 min. The
supernatant was obtained and stored at 220uC for MDA assays.
The whole paw edema tissue was rinsed in ice-cold normal saline,
and immediately placed in cold normal saline one time their
volume and homogenized at 24uC. Then the homogenate was
centrifuged at 12,0006g for 5 min. The supernatant was obtained
and stored at 220uC for the antioxidant enzymes (CAT, SOD and
GPx) activity assays. The protein concentration of the sample was
determined by the Bradford dye-binding assay (Bio-Rad, Hercules,
CA).
MDA Assay
MDA from Carr-induced edema foot was evaluated by the
thiobarbituric acid reacting substances (TBARS) method [17].
Briefly, MDA reacted with thiobarbituric acid in the acidic high
temperature and formed a red-complex TBARS. The absorbance
of TBARS was determined at 532 nm.
Measurement of Serum TNF-a by an Enzyme-Linked
Immunosorbent Assay (ELISA)
Serum levels of TNF-a were determined using a commercially
available ELISA kit (Biosource International Inc., Camarillo, CA)
according to the manufacturer’s instruction. TNF-a was deter-
mined from a standard curve. The concentrations were expressed
as pg/mL.
Antioxidant Enzyme Activity Measurements
The following biochemical parameters were analyzed to check
the antioxidant enzyme activity of inotilone in the paw edema by
the methods given below.
Total SOD activity was determined by the inhibition of
cytochrome c reduction [18]. The reduction of cytochrome c was
mediated by superoxide anions generated by the xanthine/
xanthine oxidase system and monitored at 550 nm. One unit of
SOD was defined as the amount of enzyme required to inhibit the
rate of cytochrome c reduction by 50%. Total CAT activity was
based on that of Aebi [19]. In brief, the reduction of 10 mM H2O2
in 20 mM of phosphate buffer (pH 7) was monitored by
measuring the absorbance at 240 nm. The activity was calculated
using a molar absorption coefficient, and the enzyme activity was
defined as nanomoles of dissipating hydrogen peroxide per
milligram protein per minute. Total GPx activity in cytosol was
determined according to Paglia and Valentine’s method [20]. The
enzyme solution was added to a mixture containing hydrogen
peroxide and glutathione in 0.1 mM Tris buffer (pH 7.2) and the
absorbance at 340 nm was measured. The activity was calculated
by using a calibration curve of GPx established from bovine whole
blood. A linear relationship between the activity (unit/mL) of GPx
and the reduction of NADPH absorbance at 340 nm was found
and the enzyme activity was defined as nanomoles of NADPH
oxidized per milligram protein per minute.
Protein Lysate Preparation and Western Blot Analysis
The stimulated murine macrophage cell line RAW264.7 cells
were washed with PBS and lysed in an ice-cold lysis buffer [10%
glycerol, 1% Triton X-100, 1 mM Na3VO4, 1 mM EGTA,
10 mM NaF, 1 mM Na4P2O7, 20 mM Tris buffer (pH 7.9),
100 mM b-glycerophosphate, 137 mM NaCl, 5 mM EDTA, and
one protease inhibitor cocktail tablet (Roche, Indianapolis, IN,
USA)] on ice for 1 h, followed by centrifugation at 12,0006g for
30 min at 4uC. Soft tissues were removed from individual mice
paws and homogenized in a solution containing 10 mM CHAPS,
1 mM phenylmethylsulphonyl fluoride (PMSF), 5 mg/mL, apro-
tinin, 1 mM pepstatin and 10 mM leupeptin. The homogenates
were centrifuged at 12,0006g for 20 min, and 30 mg of protein
from the supernatants was then separated on 10% sodium
dodecylsulphate–polyacrylamide gel (SDS-PAGE) and transferred
to polyvinylidene difluoride membranes. After transfer, the
membrane was blocked for 2 h at room temperature with 5%
skim milk in Tris-buffered saline-Tween (TBST; 20 mM Tris,
500 mM NaCl, pH 7.5, 0.1% Tween 20). The membranes were
then incubated with antibody in 5% skim milk in TBST for 2 h at
room temperature. The membranes were washed three times with
TBST at room temperature and then incubated with a 1:2000
dilution of anti-mouse IgG secondary antibody conjugated to
horseradish peroxidase (Sigma, St Louis, MO, U.S.A.) in 2.5%
skim milk in TBST for 1 h at room temperature. The membranes
were washed three times and the immunoreactive proteins were
detected by enhanced chemiluminescence (ECL) by using
hyperfilm and ECL reagent (Amersham International plc.,
Buckinghamshire, U.K.). The results of Western blot analysis
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the control using Kodak Molecular Imaging Software (Version
4.0.5, Eastman Kodak Company, Rochester, NY) and represented
in the relative intensities.
Histological Examination
For histological examination, biopsies of paws took 5 hrs
following the intraplantar injection of Carr. The tissue slices were
fixed in Dietric solution (14.25% ethanol, 1.85% formaldehyde,
1% acetic acid) for 1 week at room temperature, dehydrated by
graded ethanol and embedded in Paraplast (Sherwood Medical).
Sections (7 mm thick) were deparaffinized with xylene and stained
with trichromic Van Gieson, and antigen retrieval was performed
with citrate buffer, then blocked with 5% normal goat serum in
PBS and incubated with rabbit anti-COX-2 and anti-iNOS in
PBS with 5% normal goat serum. The sections were incubated
with biotinylated goat anti-rabbit IgG. After washing in PBS,
sections were processed with the Dako kit (Dako REALTM
envision TM detection system). Thus, some sections were stained
with hematoxylin and eosin, while others were processed for iNOS
and COX-2 immunohistochmistry staining. All samples were
observed and photographed with BH2 Olympus microscopy.
Every three to five tissue slices were randomly chosen from
Control, Carr, Indo and inotilone-treated (5 mg/kg) groups [21].
Statistical Analysis
Experimental results were presented as the mean 6 standard
deviation (SD) of three parallel measurements. IC50 values were
estimated using a non-linear regression algorithm (SigmaPlot 8.0;
SPSS Inc. Chicago, IL). Data obtained from animal experiments
were expressed as mean standard error (6S.E.M.). Statistical
evaluation was carried out by one-way analysis of variance
(ANOVA followed by Scheffe’s multiple range tests). Statistical
significance is expressed as
*p,0.05,
**p,0.01 and
***p,0.001.
Results
Isolation of Inotilone from PL and its Structural
Characterization
PL was isolated via extensive chromatographic purification of
the ethyl acetate-soluble fraction of the dried fruiting body. The
chemical structure of the purified yellow powder was elucidated by
NMR spectroscopy and mass spectrometry studies and it was
identified as inotilone (Fig. 1A) [9].
Cell Viability and Effect of Inotilone on LPS-induced NO
Production in Macrophages
The effect of inotilone on RAW264.7 cell viability was
determined by a MTT assay. Cells cultured with inotilone at the
concentrations (0, 1.56, 3.12, 6.25, 12.5, and 25 mM) used in the
presence of 100 ng/mL LPS for 24 h did not change cell viability
(Fig. 1B). Inotilone did not interfere with the reaction between
nitrite and Griess reagents at 25 mM (data not shown).
Unstimulated macrophages, after 24 h of incubation in culture
medium produced background levels of nitrite. When RAW264.7
macrophages were treated with different concentrations of
inotilone (0, 1.56, 3.12, 6.25, 12.5, and 25 mM) together with
LPS (100 ng/mL) for 24 h, a significant concentration-dependent
inhibition of nitrite production was detected. There was either a
significant decrease in the nitrite production of group treated with
3.12 mM inotilone (p,0.05) or very or highly significant decrease
of groups treated respectively with 6.25, 12.5 and 25 mMo f
inotilone when compared with the LPS-alone group (p,0.01 or
p,0.001). The IC50 value for inhibition of nitrite production of
inotilone was about 10.2460.35 mM (Fig. 1C).
Inhibition of LPS-induced iNOS and COX-2 Protein by
Inotilone
In order to investigate whether the inhibition of NO production
was due to a decreased iNOS and COX-2 protein level, the effect
of inotilone on iNOS and COX-2 protein expression was studied
by immunoblot. The results showed that incubation with inotilone
(0, 6.25, 12.5, and 25 mM) in the presence of LPS (100 ng/mL) for
24 hrs inhibited iNOS proteins expression in mouse macrophage
RAW264.7 cells in a dose-dependent manner (Fig. 1D). The
detection of b-actin was also performed in the same blot as an
internal control. The intensity of protein bands were analyzed
using Kodak Quantity software in three independent experiments
and showed an average of 67.1 and 13.6% down-regulation of
iNOS and COX-2 proteins after treatment with inotilone at 25mM
compared with the LPS-alone.
Effects of Inotilone on the LPS-stimulated Activation of
Mitogen-activated Protein Kinases (MAPKs)
MAPKs play critical roles in the regulation of cell growth and
differentiation, and control cellular responses to cytokines and
stresses. In particular, ERK, p38, and JNK are known to be
important for the activation of NF-kB [21,22]. To explore whether
the inhibition of NF-kB activation by inotilone is mediated
through the MAPK pathway, MAPK phosphorylation was
examined by Western blot in RAW 264.7 cells pretreated with
inotilone and then with LPS. As shown in Fig. 1E, inotilone
suppressed the LPS-induced activation of ERK, JNK, and p38
MAPKs in a time-dependent manner. However, the expression of
non-phosphorylated ERK, JNK, and P38 MAPKs was unaffected
by LPS or LPS plus inotilone. These results suggest that
phosphorylation of MAPKs may be involved in the inhibitory
effect of inotilone on LPS-stimulated NF-kB binding in RAW
264.7 cells.
Inhibition of LPS-induced MMP and NF-kB Proteins by
Inotilone
The effect of inotilone on MMP-9 activation was analyzed by
gelatin zymography and immunoblot. As shown in Fig. 2A, the
results showed that the incubation with inotilone (0, 6.25, 12.5,
and 25 mM) in the presence of LPS for 24 h MMP-9 activation in
mouse macrophage RAW264.7 cells in a dose-dependent manner.
The intensity of protein bands were analyzed by using Kodak
Quantity software in three independent experiments and showed
an average of 68.1% down-regulation of MMP-9 activation after
the treatment with inotilone at 25mM compared with the LPS-
alone. The effect of MMP-9 expression by inotilone in the
presence of LPS (100 ng/mL) for 24 h was assessed by Western
blotting. The results showed the incubation with inotilone (0, 6.25,
12.5, and 25 mM) in the presence of LPS for 24 h inhibited MMP-
9 proteins expression in mouse macrophage RAW264.7 cells in a
dose-dependent manner (Fig. 2B). The detection of b-actin was
also performed in the same blot as an internal control. The
intensity of protein bands was analyzed by using Kodak Quantity
software in three independent experiments and the result showed
an average of 58.9% down-regulation of MMP-9 proteins,
respectively, after the treatment with inotilone at 25 mM compared
with the LPS-alone.
The effect of NF-kB expression by inotilone in the presence of
LPS for 1 h was assessed by Western blotting. And the intensity of
protein bands showed an average of 79.2% increase of NF-
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the LPS-alone (Fig. 2C). Therefore, it can be concluded that
inotilone is capable of inhibiting iNOS expression in LPS induced
RAW264.7 cells via attenuation of NF-kB signaling by ERK, p38,
and JNK.
Effects of Inotilone on Carr-induced Mouse Paw Edema
Because inotilone effectively inhibited iNOS inductions in
macrophages, studies were extended to determine whether
inotilone affected acute phase inflammation in animal models.
In this study, we used Carr-induced edema because this model is
widely employed for screening the effects of anti-inflammatory
drugs. Carr-induced paw edema is shown in Fig. 3A. Inotilone
(5 mg/kg) inhibited (p,0.001) the development of paw edema
induced by Carr (10 mg/kg) at the 4
th h and the 5
th h after the
treatment, significantly. Inotilone at the concentration of 5 mg/kg,
the levels of edema volume were decreased to 56.2% of that
observed in the Carr alone group. Indo (10 mg/kg) significantly
decreased the Carr induced paw edema at the 4
th h and the 5
th h
after the treatment (p,0.001).
Effects of Inotilone on the MDA Level
The MDA level increased significantly in the edema paw at the
5
th h after Carr injection (p,0.001). However, the MDA level was
decreased significantly by treatment with inotilone (5 mg/kg)
(p,0.001), as well as 10 mg/kg Indo (Fig. 3B). The inhibition mice
MDA levels compared with the Carr group are 18.3%, 39.7%,
and 43.3%, respectively.
Effects of Inotilone on the TNF-a Level
The TNF-a level increased significantly in serum at the 5
th h
post-Carr injection (p,0.001). However, inotilone (5 mg/kg)
decreased the TNF-a level in serum at the 5
th h after Carr
injection (p,0.01), as well as 10 mg/kg Indo (Fig. 3C). In the
range of 1.25–5 mg/kg, inotilone could inhibit the level of TNF-a
to 10.6–40.3% of the observation in Carr group.
Effects of Inotilone on the NO Level
In Fig. 3D, the NO level increased significantly in the edema
serum at the 5
th h post-Carr injection (p,0.001). Inotilone (5 mg/
kg) significantly decreased the serum NO level (p,0.001).
Meanwhile, in the range of 1.25–5 mg/kg, inotilone could inhibit
the level of nitrite to 26.2–59.7% of the observation in Carr group.
The inhibitory potency was similar to that of Indo (10 mg/kg) at
the 5
th h after induction.
Effects of Inotilone on Activities of Antioxidant Enzymes
At the 5
th h after the intrapaw injection of Carr, paw edema
tissues were also analyzed for the biochemical parameters such as
CAT, SOD, and GPx activities. Carr decreased the activities of
CAT, SOD, and GPx in paw edema by 29.3%, 33.9%, and
32.1%, respectively, in comparison to control group. In the range
of 1.25–5 mg/kg, inotilone could increase the activities of CAT to
114.3%–125.6%, SOD to 108.2%–139.6%, and GPX to 108.8%–
123.5%, respectively, of that observed in Carr along group. Indo
also exhibited increase effects in the activities of CAT (129.2%),
SOD (140.7%), and GPx (124.1%) in comparison to Carr group
Figure 1. The chemical structure of inotilone (A) and the effects of inotilone on lipopolysaccharide (LPS)-induced cell viability (B),
NO production (C), inhibition of iNOS and COX-2 protein expression (D), and MAPK (JNK, p38, and ERK) protein expression (E) were
evaluated in RAW264.7 cells. Cells were incubated for 24 h or 5, 10, 15, 30, and 60 mins with 100 ng/mL of LPS in the absence or presence of
inotilone (0, 1.56, 3.12, 6.25, 12.5, and 25 mM). Inotilone was added 1 h before the incubation with LPS. Cell viability was performed by using MTT
assay. Nitrite concentration in the medium was determined by using Griess reagent. Lysed cells were then prepared and subjected to Western
blotting by using an antibody specific for iNOS, COX-2, and MAPK. b-actin was used as an internal control. The data were presented as mean 6 S.D.
for three different experiments performed in triplicate. **p,0.01 and ***p,0.001 were compared with LPS-alone group.
doi:10.1371/journal.pone.0035922.g001
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PLoS ONE | www.plosone.org 5 May 2012 | Volume 7 | Issue 5 | e35922Figure 2. Inotilone suppresses LPS-induced MMP-9 activities (A), MMP-9 protein (B), and NF-kB expressions (C) in RAW264.7 cells.
Cells were incubated for 24 h or 1 h with 100 ng/mL of LPS in the absence or the presence of inotilone (0, 6.25, 12.5, and 25 mM). Inotilone was added
1 h before the incubation with LPS. The conditioned media were collected MMP-9 activities determined by gelatin zymography. MMP-9 activities
were quantified by densitometric analysis. Representative Western blot from two separate experiments was shown. MMP-9 and NF-kB levels were
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PLoS ONE | www.plosone.org 6 May 2012 | Volume 7 | Issue 5 | e35922(P,0.01) (Table 1). These data implied that the protective effects
of inotilone might be attributed to its elevation in the antioxidant
enzymes activities of Carr induced mice.
Effects of Inotilone on Carr-induced iNOS and COX-2
Protein Expression in Mouse Paw Edema
To investigate whether the inhibition of NO production was
due to a decreased iNOS and COX-2 protein level, the effect of
inotilone on iNOS and COX-2 proteins expression were studied
by Western blot. The results showed that the injection of inotilone
(5 mg/kg) on Carr-induced for 5 h inhibited iNOS and COX-2
proteins expression in mouse paw edema (Fig. 4A). The intensity
of protein bands was analyzed by using Kodak Quantity software
in three independent experiments and showed an average of
76.7% and 87.2% reduction of iNOS and COX-2 protein,
respectively, after treatment with inotilone at 5 mg/kg compared
with the Carr-induced alone. In addition, the protein expression
showed an average of 46.1% and 57.3% reduction of iNOS and
COX-2 protein after the treatment with Indo at 10.0 mg/kg
compared with the Carr-induced alone. The down-regulation of
iNOS and COX-2 activity of the inotilone (5 mg/kg) was better
than Indo (10.0 mg/kg).
calculated with reference to a LPS-stimulated culture. The data were presented as mean 6 S.D. for three different experiments performed in triplicate.
###compared with sample of control group. **p,0.01 and ***p,0.001 were compared with LPS-alone group.
doi:10.1371/journal.pone.0035922.g002
Figure 3. Effects of inotilone and Indo on hind paw edema induced by Carr in mice (A), the tissue MDA concentration of foot in mice
(B), Carr-induced NO (C), and TNF-a (D) concentrations of serum at the 5
th h in mice. Each value represents as mean 6 S.E.M.
###p,0.001
as compared with the control group. *p,0.05, **p,0.01, and ***p,0.001 as compared with the Carr group (one-way ANOVA followed by Scheffe’s
multiple range test).
doi:10.1371/journal.pone.0035922.g003
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Protein Expressions in Mouse Paw Edema
The results showed that the injection of inotilone (5 mg/kg) on
Carr-induced for 5 h inhibited MMP-9 and NF-kB proteins
expression in mouse paw edema (Fig. 4B and 4C). The intensity of
protein bands was analyzed by using Kodak Quantity software in
three independent experiments and the result of it showed an
average of 69.3% reduction of MMP-9 protein after the treatment
with inotilone at 5 mg/kg compared with the Carr-induced alone.
In addition, the protein expression showed an average of 57.5%
reduction of MMP-9 protein after the treatment with Indo at
10.0 mg/kg compared with the Carr-induced alone (Fig. 4B). And
the intensity of protein bands showed an average of 96.8%
increase of NF-kB protein (p,0.001) (Fig. 4C).
Inotilone Modulates the Activation of MAPK Pathways in
Mouse Paw Edema
The activation of MAPK pathways in particular the phosphor-
ylation of ERK1/2, JNK, and p38 expression were investigated by
Western blot in paw edema tissues homogenates at the 5
th h after
Carr injection. A significant increase in p-ERK1/2, p-JNK, and p-
p38 levels was observed in Carr-treated mice (Fig. 4D). The
treatment of mice with inotilone significantly reduced the level of
p-ERK1/2, p-JNK, and p-p38 levels in mouse paw edema. On the
contrary, inotilone treatment prevented the Carr-induced expres-
sion of these kinases. The intensity of protein bands were analyzed
by using Kodak Quantity software in three independent experi-
ments and showed an average of 59.8%, 61.7%, and 71.8%
reduction of p-ERK1/2, p-JNK, and p-p38 proteins after the
treatment with inotilone at 5 mg/kg compared with the Carr-
induced alone (p,0.001) (Fig. 4D).
Histological Examination
Paw biopsies of the control mice showed marked cellular
infiltration in the connective tissue. The infiltrates accumulated in
collagen fibers and intercellular spaces. Paw biopsies of mice
treated with inotilone (5 mg/kg) showed a reduction in inflam-
matory responses induced by Carr. Histologically, inflammatory
cells were reduced in number and confined to the surroundings of
the vascular areas. Intercellular spaces did not show any cellular
infiltrations. Collagen fibers were regular in shape and showed a
reduction in intercellular spaces. Moreover, the hypodermis
connective tissues were not damaged (Fig. 5A). Neutrophils were
increased with Carr treatment (Fig. 5B). Indo and inotilone (5 mg/
kg) could decrease the neutrophils numbers as compared to the
Carr-treated group (Fig. 5C and 5D). No inflammation, tissue
destruction, iNOS and COX-2 immunoreactive cells (Fig. 5E and
5I). At the 5
th h after intraplantar Carr injection, numerous iNOS
and COX-2 immunoreactive cells were observed in the brown site
of paw tissue (Fig. 5F and 5J). Administration of Indo and inotilone
(5 mg/kg) 30 min prior to the Carr injection markedly reduced
the increase in iNOS amd COX-2 immunoreactive cells in paws
(Fig. 5G, 5H, 5K, and 5L).
Discussion
Inflammation represents a highly coordinated set of events that
allow tissues to respond to injury, and it requires the participation
of various cell types expressing and reacting to diverse mediators in
a sequential manner [23]. In the present study, we demonstrated
the anti-inflammatory activities of inotilone in both in vitro and in
vivo experimental systems, by using LPS-stimulated RAW264.7
macrophages and a mouse model of topical inflammation
respectively. The inhibitory activities against iNOS as shown in
in vitro assays appear to confer on inotilone a potent in vivo efficacy
in mouse suggesting its potential therapeutic usage as a novel
topical anti-inflammatory source of health food. The pathology of
inflammation is initiated by complex processes triggered by
microbial pathogens such as LPS which is a prototypical
endotoxin. LPS can directly activate macrophages which trigger
the production of inflammatory mediators, such as NO, prosta-
glandin E2 (PGE2), TNF-a and leukotrienes [24]. However, no
report has been issued on the anti-inflammatory effect of inotilone
in vivo and the mode of action involved. Thus, this study was aimed
to evaluate the anti-inflammatory effect of inotilone by screening
the effects of inotilone on LPS-induced pro-inflammatory mole-
cules in vitro and on acute phase inflammation in vivo. And, we also
evaluated the mechanism of inotilone on MMP-9 and NF-kB
expressions associated MAPK signaling pathways in the anti-
inflammation.
LPS-induced macrophage activation increased the production
of pro-inflammatory cytokines, NO by iNOS and PGE2 by COX-
2, which are the main cytotoxic and pro-apoptotic mechanisms
participating in the innate response in many mammals [25].
Therefore, LPS which stimulated macrophages can be effectively
used as a model to study inflammation and potential anti-
inflammatory mediators with their action mechanisms. Although
iNOS plays a pivotal role in immunity against infectious agents by
producing an excess amount of NO, this enzyme has come into the
spotlight for its detrimental roles in inflammation-related diseases
[26]. In vitro models such as macrophage cells or other cell lines are
useful materials with a steady high-level production of NO. The
mechanisms by which inotilone inhibits macrophage functions
Table 1. Effects of inotilone and indomethacin (Indo) on changes in CAT, SOD and GPx activities was studied on Carr-induced
mice paw edema (5
th h).
Groups Catalase (U/mg protein) SOD (U/mg protein) GPx (U/mg protein)
Control 4.7560.31 25.2860.23 21.9660.28
Carr 3.3660.23
### 16.7160.18
### 14.9260.13
###
Carr + Indo 4.3460.16** 23.5160.14** 18.5260.23**
Carr + inotilone (1.25 mg/Kg) 3.8460.22 18.0860.08 16.2460.13
Carr + inotilone (2.5 mg/Kg) 4.0760.18* 21.4360.25* 17.8560.37*
Carr + inotilone (5 mg/Kg) 4.2260.25** 23.3360.21** 18.4360.24**
Each value represents as mean 6 S.E.M.
###p,0.001 as compared with the control group. *p,0.05 and **p,0.01 as compared with the Carr group (one-way ANOVA
followed by Scheffe’s multiple range test).
doi:10.1371/journal.pone.0035922.t001
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inotilone in RAW264.7 macrophages using MTT assay has
indicated that inotilone even at 25 mM did not affect the viability
of RAW264.7 cells. Inotilone inhibited iNOS expression in LPS-
stimulated macrophages and subsequently inhibited the NO
production, whereas it decreased the enzyme activity of COX-2
instead of its expression to reduce PGE2 production [12]. In
addition, Carr-induced inflammatory response has been linked to
neutrophil infiltration release NO as well as that of PGE2. Results
in vitro showed that inotilone suppressed LPS-induced production
of NO, and the protein expression of iNOS and COX-2. The
similar results for inotilone inhibits LPS-induced NO and PGE2
production through modulating iNOS expression and COX-2
enzyme activity [12].
Inhibiting NF-kB and MAPK pathways have been suggested as
the two major mechanisms underlying the attenuation of LPS-
induced inammatory cytokine production. NF-kB plays a crucial
role as the transcription factor in regulating many of the pro-
inammatory cytokine genes. LPS stimulation elicits a cascade
leading to the activation of NF-kB [7]. The MAPKs play a critical
role in the regulation of cell growth and differentiation and in the
control of cellular responses to cytokines and stressors. Moreover,
MAPKs are involved in the LPS-induced signalling pathway by
which iNOS is expressed [27]. In the present study, we have
demonstrated that the phosphorylation of MAPKs can be induced
by LPS. The treatment with inotilone was found to significantly
inhibit LPS-induced JNK, ERK, and p38 phosphorylation at 5,
10, 15, 30, and 60 min. Therefore, this suggests that JNK, ERK,
and p38 are involved in the inhibition by inotilone of LPS-
Figure 4. Inhibition of iNOS, COX-2 (A), MMP-9 (B), NF-kB (C), and MAPK (JNK, p38, and ERK) (D) protein expressions by inotilone
induced by Carr of foot at the 5
th h in mice. Suspended tissue were then prepared and subjected to Western blotting using an antibody specific
for iNOS and COX-2. b-actin was used as an internal control. A representative Western blot from two separate experiments is shown. Relative iNOS,
COX-2, MMP-9, NF-kB, and MAPK (JNK, p38, and ERK) protein levels were calculated with reference to a Carr-injected mouse. The data were presented
as mean 6 S.D. for three different experiments performed in triplicate.
###p,0.001 as compared with the control group. *p,0.05, **p,0.01 and
***p,0.001 as compared with the Carr group (one-way ANOVA followed by Scheffe’s multiple range test).
doi:10.1371/journal.pone.0035922.g004
Figure 5. Histological appearances of mouse hind footpads after subcutaneously injecting 0.9% saline (Control group) or Carr, and
then stained with H&E stain, while others were processed for iNOS and COX-2 immunohistochmistry staining. (A). Control mice: show
the normal appearance of dermis and subdermis without any significant lesions, (F) iNOS and (J) COX-2 immunoreactive cells existed in the paws of
normal mice; (B). Carr Only: Hemorrhage with moderately extravascular red blood cell and large amounts of inflammatory leucocytes, mainly
neutrophils infiltrating the subdermis interstitial tissue. Moreover, the detail of the subdermis layer show enlargement of the interstitial space caused
by the exudate fluid in the edema, (G) numerous iNOS and (K) COX-2 immunoreactive cells were observed in the brown site of paw tissue; (C). Carr +
Indo 10 mg/kg (i.p.) (1006): there were obvious morphological alterations and improvements, (H) iNOS and (L) COX-2 immunoreactive cells; (D). Carr
+ inotilone: there were significant morphological alterations compared to the tissue with Carr treatment only. The lesions showed no hemorrhage
and the number of neutrophils infiltrating the subdermis interstitial tissue was markedly reduced and also in (I) iNOS and (M) COX-2 immunoreactive
cells in paws. Scale bar=100 mm. There were markedly fewer inflammatory cells, and iNOS and COX-2 immunoreactive cells in the paws of Carr
treated mice. The infiltrating cells were predominantly neutrophils (N; arrows). The brown staining indicated the interaction of primary and secondary
antibodies and the presence of iNOS and COX-2.
doi:10.1371/journal.pone.0035922.g005
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(1999) suggested that activation of ERK is thought to be involved
in LPS-induced macrophage responses [28]; in addition, JNK and
p38 are activated by LPS stimulation and they have been
postulated to play important roles in controlling iNOS gene
expression [29]. In this study, we found that the treatment of
inotilone blocked the activation of ERK1/2, JNK, and p38
MAPK, suggesting that inotilone suppresses LPS-induced NF-kB
translocation by inhibiting the activation of these intracellular
signaling cascades and it decreases the protein level of iNOS.
MMPs are involved in several pathological processes including
cancers and inflammation. Among the MMPs, MMP-9 is secreted
by macrophages regulates leukocyte migration in inflammatory
diseases [5]. MMP-9 regulation involves transcriptional regulation,
post-translational cleavage, and antagonism by physiological
inhibitors [30]. In transcriptional regulation, MMP-9 expression
is controlled by transcriptional factors including activator protein-
1 (AP-1) and NF-kB, which bind to the corresponding binding
sites in the MMP-9 promoter region [31]. In various kinds of cells,
different stimuli induce MMP-9 expression through activation of
the MEK-ERK or phosphoinositide 3-kinase (PI3K)-Akt signaling
pathways, which subsequently activate AP-1 and NF-kB [32].
Also, p38 MAPK up-regulates MMP-9 expression in Raw 264.7
cells stimulated with LPS [33]. However, the upstream regulatory
pathways that control the expression and secretion of MMP-9 are
very complex and not well understood. Inotilone also decreased
the phosphorylation of Akt and PI3K expression [12]. Our results
are that inotilone inhibited the activities and the expressions of
MMP-9 through decreasing of ERK signaling pathway which
subsequently decrease NF-kB expression.
Carr-induced paw edema is a well-established model of edema
formation which is commonly used for the screening of anti-
inflammatory drugs. The intraplantar injection of Carr-induces
inflammatory responses, including increases in paw volume and
neutrophil infiltration [34]. Recent studies have shown that Carr-
induced peripheral release of NO as well as that of PGE2 [26]. NO
plays a major role in edema formation in inflammatory responses
and tissue injury and Carr-induced the release of TNF-a level in
the tissue [24]. Our results revealed that inotilone and Indo
significantly inhibited the development of edema the 4
th h and the
5
th h after treatment. It was found that the injection of Carr into
the mice paw induces the liberation of bradykinin, which later
induces the biosynthesis of prostaglandin and other autacoids,
which are responsible for the formation of the inflammatory
exudates [21]. Our Carr-induced mice paw edema model enabled
us to demonstrate the ability of inotilone to inhibit edema induced
by acute inflammation. These results in conjunction with the
marked inhibition of LPS-induced NO and TNF-a productions by
inotilone in macrophages imply that the anti-edema effects of
inotilone might result from its inhibition of NO and TNF-a
syntheses in the peripheral tissues. The proinflammatory cytokines
such as TNF-a and IL-1b are small secreted proteins, which
mediate and regulate inflammation. TNF-a induces a number of
physiological effects including septic shock, inflammation, and
cytotoxicity [14]. Also, TNF-a is a mediator of Carr-induced
inflammatory incapacitation, and it is able to induce the further
release of kinins and leukotrienes, which is suggested to have an
important role in the maintenance of long-lasting nociceptive
response [3]. In this study, we found that inotilone decreased the
TNF-a level after the Carr injection.
The Carr-induced inflammatory response has been linked to
neutrophils infiltration and the production of neutrophils-derived
free radicals, as well as the release of other neutrophils-derived
mediators [4]. Many researchers demonstrated that inflammatory
effect induced by Carr is associated with free radical. Free radical,
prostaglandin and NO will be released when administrating with
Carrfor1–6 h[3].ThereactionofNOwithsuperoxideanionforms
peroxynitrite, a potent cytotoxic oxidant eliciting lipid peroxidation
and cellular damage. MDA, an indicator of lipid peroxidation, and
antioxidantenzymes(CAT,SOD,andGPx)werealsomeasuredfor
evaluatingtheabilitytoscavengeradicals.Thus,inflammatoryeffect
would result in the accumulation of MDA [35]. In this study, there
were significantly decreases in MDA level with inotilone treatment.
Furthermore, there was significantly increase in CAT, SOD, and
GPx activities with inotilone treatment. We assume the suppression
of MDA production is probably due to the increases of CAT, SOD,
and GPx activities.
The MAPk family plays important roles in regulation of cell
proliferation and cell death in response to various cellular stresses.
During Carr-treated mice, oxidative stress and inflammatory
cytokines activated MAP kinase kinases, leading to phosphoryla-
tion of ERK1/2, JNK, and p38 [36]. In the present study, we have
observed an increase of phosphorylated MAPKs in the paw edema
tissues at the 5
th h after Carr which is significantly reduced by the
treatment with inotilone. Therefore, inotilone might alter NADPH
oxidase activity through the inhibition of MAPK phosphorylation.
Recent study also showed that the mechanism of action of
inflammation involved the inhibition of the NADPH-oxidase-
dependent superoxide production, the reduction of the intracel-
lular GSH/GSSG ratio and prevention of the activation of the
nuclear transcription factor NF-kB, which is an important
mediator of inflammation [37].
Natural products are a valuable source of novel bioactive
secondary metabolites. Various bioassays exist in which the anti-
inflammatory activity of these products can be evaluated, having
demonstrated that inotilone possesses anti-inflammatory activity in
vitro and in vivo model of inflammation. In this model of in vivo acute
inflammation, TNF-a and NO release in mice serum dropped
markedly upon pretreatment with inotilone. It has been demon-
stratedthatseveralnaturalproductcompoundswhichfallunderthe
class of phenolic compounds act as strong inhibitors of NF-kB
activation [38]. Inotilone also inhibited MMP-9 induction via
Figure 6. Proposed mechanism of inotilone inhibition of LPS-
induced inflammation in RAW 264.7 cells. Inotilone abrogates the
phosphorylation of MAPKs/IKK and subsequently inactivates NF-kB,
which may result from inotilone down-regulation of iNOS and COX-2.
Arrows indicate the main inflammatory pathway activated by LPS
stimulation. The prohibition signs indicate the inhibitory effects of
inotilone. TLR4; Toll-like receptor 4.
doi:10.1371/journal.pone.0035922.g006
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has been reported to up-regulate MMP-9 production in macro-
phages and neutrophils, astrocytes, and mast cells indicating the
possible involvement of this enzyme in mediating the local
infiltration of these inflammatory cells. From the present results, it
was indicated that inotilone may regulate the above mentioned
inflammatory responses through both inactivation of NF-kB and
MAPKs.
In conclusion, inotilone suppresses LPS-induced MMP-9
expression by inhibiting the activation of NF-kB via ERK, p38,
and JNK signaling pathways in RAW 264.7 cells. This is the first
study showing that inotilone inhibits LPS-stimulated RAW 264.7
cells through specific inhibition of NF-kB-dependent MMP-9
expression via ERK, p38, and JNK signaling pathways (Fig. 6).
And it is associated with the increase in the activities of antioxidant
enzymes (CAT, SOD, and GPx) and inhibit of iNOS, COX-2,
MMP-9, NF-kB, and MAPK expressions in vivo. These results
suggest that inotilone represents a potential anti-inflammatory
agent and this new beneficial effect may expand future researches
on anti-inflammatory properties of inotilone in vitro and in vivo.
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